CureVac Belgium

Ottignies-Louvain-la-Neuve ·KBO/BCE: BE 0781.532.859

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	01-08-2025	1 d late	2025-00359235
31-12-2023	31-07-2024	08-11-2024	100 d late	2024-00531241
31-12-2022	31-07-2023	20-07-2023	11 d early	2023-00252878

Metric	This company	Sector median	Position in the sector
Solvency	8.2%	53.6%	better than 15% of 42 sector peers
Net result	€103k	€-16k	better than 75% of 41 sector peers
Equity	€310k	€644k	better than 32% of 42 sector peers
Gross operating margin	€4.59M	€7k	better than 95% of 33 sector peers
Total assets	€3.78M	€1.71M	better than 63% of 42 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.78M
Fixed assets	21/28	€52k
Financial fixed assets	28	€52k
Current assets	29/58	€3.72M
Amounts receivable within one year	40/41	€3.25M
Cash & bank	54/58	€447k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.78M
Equity	10/15	€310k
Contributions / capital	10/11	€62k
Reserves	13	€6k
Accumulated profits (losses)	14	€243k
Amounts payable	17/49	€3.47M
Amounts payable within one year	42/48	€3.45M
Trade debts payable within one year	44	€47k
Income statement
Gross operating margin	9900	€4.59M
Operating result	9901	€226k
Financial charges	65	€64k
Result before taxes	9903	€163k
Income taxes	67/77	€59k
Net result for the period	9904	€103k
Result to be appropriated	9905	€103k

Summary

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	03-02-2022
Status	Active
Postal code	1348